Literature DB >> 21266348

HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells.

Ashwani Khurana1, Peng Liu, Pasquale Mellone, Laura Lorenzon, Bruno Vincenzi, Kaustubh Datta, Bo Yang, Robert J Linhardt, Wilma Lingle, Jeremy Chien, Alfonso Baldi, Viji Shridhar.   

Abstract

HSulf-1 modulates the sulfation states of heparan sulfate proteoglycans critical for heparin binding growth factor signaling. In the present study, we show that HSulf-1 is transcriptionally deregulated under hypoxia in breast cancer cell lines. Knockdown of HIF-1α rescued HSulf-1 downregulation imposed by hypoxia, both at the RNA and protein levels. Chromatin immunoprecipitation with HIF-1α and HIF-2α antibodies confirmed recruitment of HIF-α proteins to the two functional hypoxia-responsive elements on the native HSulf-1 promoter. HSulf-1 depletion in breast cancer cells resulted in an increased and sustained bFGF2 (basic fibroblast growth factor) signaling and promoted cell migration and invasion under hypoxic conditions. In addition, FGFR2 (fibroblast growth factor receptor 2) depletion in HSulf-1-silenced breast cancer cells attenuated hypoxia-mediated cell invasion. Immunohistochemical analysis of 53 invasive ductal carcinomas and their autologous metastatic lesions revealed an inverse correlation for the expression of HSulf-1 to CAIX in both the primary tumors (P ≥ 0.0198) and metastatic lesions (P ≥ 0.0067), respectively, by χ(2) test. Finally, HSulf-1 expression levels in breast tumors by RNA in situ hybridization showed that high HSulf-1 expression is associated with increased disease-free and overall survival (P ≥ 0.03 and P ≥ 0.0001, respectively). Collectively, these results reveal an important link between loss of HSulf-1 under hypoxic microenvironment and increased growth factor signaling, cell migration, and invasion. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266348      PMCID: PMC3059381          DOI: 10.1158/0008-5472.CAN-10-3059

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

Review 1.  Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters.

Authors:  P W Park; O Reizes; M Bernfield
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

2.  Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase.

Authors:  G K Dhoot; M K Gustafsson; X Ai; W Sun; D M Standiford; C P Emerson
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

3.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.

Authors:  Nathalie M Mazure; Caroline Chauvet; Brigitte Bois-Joyeux; Marguerite-Anne Bernard; Habib Nacer-Chérif; Jean-Louis Danan
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

5.  Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

Authors:  Balaji Krishnamachary; Shannon Berg-Dixon; Brian Kelly; Faton Agani; David Feldser; Gloria Ferreira; Narayan Iyer; Jessica LaRusch; Brian Pak; Panthea Taghavi; Gregg L Semenza
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

6.  HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice.

Authors:  Maria Mastrogiannaki; Pavle Matak; Brian Keith; M Celeste Simon; Sophie Vaulont; Carole Peyssonnaux
Journal:  J Clin Invest       Date:  2009-04-06       Impact factor: 14.808

7.  Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.

Authors:  Peng Liu; Ashwani Khurana; Ramandeep Rattan; Xiaoping He; Steve Kalloger; Sean Dowdy; Blake Gilks; Viji Shridhar
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

8.  Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans.

Authors:  Megumi Morimoto-Tomita; Kenji Uchimura; Zena Werb; Stefan Hemmerich; Steven D Rosen
Journal:  J Biol Chem       Date:  2002-10-03       Impact factor: 5.157

9.  Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

Authors:  Monika Schindl; Sebastian F Schoppmann; Hellmut Samonigg; Hubert Hausmaninger; Werner Kwasny; Michael Gnant; Raimund Jakesz; Ernst Kubista; Peter Birner; Georg Oberhuber
Journal:  Clin Cancer Res       Date:  2002-06       Impact factor: 12.531

10.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

View more
  29 in total

1.  Basic fibroblast growth factor in an animal model of spontaneous mammary tumor progression.

Authors:  Steven Kao; Jeffrey Mo; Andrew Baird; Brian P Eliceiri
Journal:  Oncol Rep       Date:  2012-03-07       Impact factor: 3.906

2.  Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer.

Authors:  Robert Hoffmann; Sayantani Sarkar Bhattacharya; Debarshi Roy; Boris Winterhoff; Ralf Schmidmaier; Keith Dredge; Edward Hammond; Viji Shridhar
Journal:  Biochem Pharmacol       Date:  2020-04-28       Impact factor: 5.858

3.  MicroRNA-195 inhibits human gastric cancer by directly targeting basic fibroblast growth factor.

Authors:  J Wang; L Li; M Jiang; Y Li
Journal:  Clin Transl Oncol       Date:  2017-05-12       Impact factor: 3.405

4.  HEXIM1 down-regulates hypoxia-inducible factor-1α protein stability.

Authors:  I-Ju Yeh; Ndiya Ogba; Heather Bensigner; Scott M Welford; Monica M Montano
Journal:  Biochem J       Date:  2013-12-01       Impact factor: 3.857

5.  Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin.

Authors:  Salma Abdi Mahmoud; Mohammed Mohammed Ibrahim; Ahmed Hago Musa; Yuhong Huang; Jun Zhang; Jingwen Wang; Yuanyi Wei; Li Wang; Shunting Zhou; Boyi Xin; Wei Xuan; Jianwu Tang
Journal:  J Cell Commun Signal       Date:  2017-12-23       Impact factor: 5.782

6.  Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme.

Authors:  Fachen Wang; Hui Jiang; Shanjun Wang; Bing Chen
Journal:  Cell Mol Neurobiol       Date:  2017-02-17       Impact factor: 5.046

7.  Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.

Authors:  Ashwani Khurana; Deok Jung-Beom; Xiaoping He; Sung-Hoon Kim; Robert C Busby; Laura Lorenzon; Massimo Villa; Alfonso Baldi; Julian Molina; Matthew P Goetz; Viji Shridhar
Journal:  Clin Exp Metastasis       Date:  2013-02-15       Impact factor: 5.150

8.  Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.

Authors:  J H Kim; C Chan; C Elwell; M S Singer; T Dierks; H Lemjabbar-Alaoui; S D Rosen; J N Engel
Journal:  Cell Microbiol       Date:  2013-04-09       Impact factor: 3.715

9.  Role of heparan sulfatases in ovarian and breast cancer.

Authors:  Ashwani Khurana; Daniah Beleford; Xiaoping He; Jeremy Chien; Viji Shridhar
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

10.  An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma.

Authors:  Yan Zhang; Lin Fang; Quan'an Zhang; Qin Zheng; Jinlong Tong; Xiaohui Fu; Xiaoqing Jiang; Changqing Su; Junnian Zheng
Journal:  Mol Oncol       Date:  2012-11-07       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.